BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 25800274)

  • 41. Inflammasome Activation by CD8
    Cardoso TM; Lima JB; Bonyek-Silva Í; Nunes S; Feijó D; Almeida H; Silva J; Barral A; Boaventura V; Borges VM; Zamboni DS; Pedreira de Carvalho L; Carvalho EM; Tavares NM; Brodskyn C
    J Invest Dermatol; 2021 Jan; 141(1):209-213.e2. PubMed ID: 32544477
    [No Abstract]   [Full Text] [Related]  

  • 42. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?
    McMahon-Pratt D; Alexander J
    Immunol Rev; 2004 Oct; 201():206-24. PubMed ID: 15361243
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytotoxic activity in cutaneous leishmaniasis.
    Campos TM; Costa R; Passos S; Carvalho LP
    Mem Inst Oswaldo Cruz; 2017 Nov; 112(11):733-740. PubMed ID: 29091132
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Indications of the protective role of natural killer cells in human cutaneous leishmaniasis in an area of endemicity.
    Maasho K; Sanchez F; Schurr E; Hailu A; Akuffo H
    Infect Immun; 1998 Jun; 66(6):2698-704. PubMed ID: 9596736
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis.
    de Moura TR; Novais FO; Oliveira F; Clarêncio J; Noronha A; Barral A; Brodskyn C; de Oliveira CI
    Infect Immun; 2005 Sep; 73(9):5827-34. PubMed ID: 16113301
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD8 T cells and Mycobacterium tuberculosis infection.
    Lin PL; Flynn JL
    Semin Immunopathol; 2015 May; 37(3):239-49. PubMed ID: 25917388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Review on the Role of Host Immune Response in Protection and Immunopathogenesis during Cutaneous Leishmaniasis Infection.
    Dubie T; Mohammed Y
    J Immunol Res; 2020; 2020():2496713. PubMed ID: 32656269
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Leishmaniasis: effect of factors present in serum].
    Savoia D; Cestaro A; Biglino S
    G Batteriol Virol Immunol; 1990; 83(1-12):118-24. PubMed ID: 2133319
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conundrums in leishmaniasis.
    Saha B; Bhattacharjee S; Sarkar A; Bhor R; Pai K; Bodhale N
    Cytokine; 2021 Sep; 145():155304. PubMed ID: 33004260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adhesion molecule expression patterns indicate activation and recruitment of CD4+ T cells from the lymph node to the peripheral blood of early cutaneous leishmaniasis patients.
    Costa RP; Gollob KJ; Machado PR; Bacellar OA; Almeida RP; Barral A; Barral-Netto M; Carvalho EM; Dutra WO
    Immunol Lett; 2003 Dec; 90(2-3):155-9. PubMed ID: 14687718
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ageing dangerously; homing of senescent CD8 T cells in cutaneous Leishmaniasis.
    Milling S
    Immunology; 2020 Apr; 159(4):355-356. PubMed ID: 32182636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Skin dendritic cells in murine cutaneous leishmaniasis.
    Udey MC; von Stebut E; Mendez S; Sacks DL; Belkaid Y
    Immunobiology; 2001 Dec; 204(5):590-4. PubMed ID: 11846222
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In situ characterization of the human host response to Leishmania panamensis.
    Palma GI; Saravia NG
    Am J Dermatopathol; 1997 Dec; 19(6):585-90. PubMed ID: 9415615
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vaccination with Leishmania mexicana LPG induces PD-1 in CD8⁺ and PD-L2 in macrophages thereby suppressing the immune response: a model to assess vaccine efficacy.
    Martínez Salazar MB; Delgado Domínguez J; Silva Estrada J; González Bonilla C; Becker I
    Vaccine; 2014 Mar; 32(11):1259-65. PubMed ID: 24462405
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD8+ T cells are preferentially activated during primary low dose leishmania major infection but are completely dispensable during secondary anti-Leishmania immunity.
    Okwor IB; Jia P; Mou Z; Onyilagha C; Uzonna JE
    PLoS Negl Trop Dis; 2014; 8(11):e3300. PubMed ID: 25412267
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leishmania major infection in mice primes for specific major histocompatibility complex class I-restricted CD8+ cytotoxic T cell responses.
    da Conceição-Silva F; Perlaza BL; Louis JA; Romero P
    Eur J Immunol; 1994 Nov; 24(11):2813-7. PubMed ID: 7957573
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is the in situ inflammatory reaction an important tool to understand the cellular immune response in American tegumentary leishmaniasis?
    Morgado FN; Schubach A; Rosalino CM; Quintella LP; Santos G; Salgueiro M; Conceição-Silva F
    Br J Dermatol; 2008 Jan; 158(1):50-8. PubMed ID: 17944980
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Highlighting the Relevance of CD8
    Kwarteng A; Asiedu E; Koranteng KK; Asiedu SO
    Front Immunol; 2021; 12():714052. PubMed ID: 34603287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Histopathology, humoral and cellular immune response in the murine model of Leishmania (Viannia) shawi.
    Passero LF; Marques C; Vale-Gato I; Corbett CE; Laurenti MD; Santos-Gomes G
    Parasitol Int; 2010 Jun; 59(2):159-65. PubMed ID: 20060062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytokines in the immunity and immunopathogenesis in leishmaniases.
    Saha B; Silvestre R
    Cytokine; 2021 Sep; 145():155320. PubMed ID: 33127260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.